MBOT
Microbot Medical Inc.
+0.01 (+0.71%)1.45USD97.7K成交股數97.4M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 241K | 105K | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | 884K | 103K | – | – | – | – | – | – | – | – | – | – |
| 毛利 | −643K | 2K | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | -266.8% | 1.9% | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.9M | 1.3M | 1.5M | 1.2M | 2.1M | 1.5M | 2.1M | 1.4M | 1.2M | 1.1M | 1.6M | 1.4M |
| 銷售管理費用 | 3.7M | 3.0M | 2.6M | 2.7M | 1.6M | 1.6M | 1.2M | 1.1M | 1.2M | 938K | 932K | 959K |
| 營業利益 | −6.2M+66% | −4.3M+43% | −4.1M+25% | −3.9M+54% | −3.7M+56% | −3.0M+46% | −3.3M+30% | −2.5M+8% | −2.4M | −2.1M | −2.5M | −2.3M |
| 營業利益率 | -2,567.6% | -4,114.3% | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −5.6M+61% | −3.7M+41% | −3.5M+8% | −3.6M+45% | −3.5M+48% | −2.6M-18% | −3.2M+31% | −2.5M+8% | −2.4M | −3.2M | −2.4M | −2.3M |
| 淨利率 | -2,334.9% | -3,496.2% | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.08-20% | -0.05-38% | -0.04-80% | -0.07-59% | -0.10-41% | -0.08-65% | -0.20-5% | -0.17-32% | -0.17 | -0.23 | -0.21 | -0.25 |
| 稀釋股數 | 67.2M | 67.2M | 45.8M | 48.1M | 36.5M | 31.1M | 16.5M | 14.8M | 14.1M | 10.2M | 11.7M | 9.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 3.2M | 3.7M | 3.9M | 6.7M | 4.1M | 3.2M | 479K | 2.5M | 1.2M | 2.5M | 1.3M | 5.7M |
| 應收帳款 | 176K | 105K | – | – | – | – | – | – | – | – | – | – |
| 存貨 | 2.9M | 2.3M | 584K | – | – | – | – | – | – | – | – | – |
| 總資產 | 73.4M | 78.1M | 81.5M | 81.8M | 33.1M | 30.9M | 5.2M | 7.4M | 7.4M | 8.3M | 8.9M | 10.9M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 4.4M | 4.0M | 4.0M | 3.5M | 2.8M | 1.9M | 1.4M | 1.4M | 1.2M | 3.8M | 1.5M | 1.4M |
| 股東權益 | 68.9M | 74.1M | 77.6M | 78.2M | 30.4M | 29.0M | 3.8M | 6.1M | 6.2M | 4.5M | 7.4M | 9.5M |
| 負債比 | 6.0% | 5.1% | 4.9% | 4.3% | 8.4% | 6.3% | 26.9% | 18.5% | 16.3% | 45.9% | 17.2% | 13.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −5.1M+76% | – | – | – | −2.9M | – | – | −2.4M | – | – | – |
| 資本支出 | – | 108K | – | – | – | 13K | – | – | 14K | – | – | – |
| 自由現金流 | – | −5.2M+79% | – | – | – | −2.9M | – | – | −2.4M | – | – | – |
| 折舊攤銷 | – | 12K | – | – | – | 15K | – | – | 28K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -4,915.2% | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −13.1M | –% | -0.29 | −13.1M |
| FY2024 | – | – | −11.4M | –% | -0.73 | −8.9M |
| FY2023 | – | – | −10.7M | –% | -1.05 | −8.6M |
| FY2022 | – | – | −13.2M | –% | -1.81 | −11.6M |
| FY2021 | – | – | −11.3M | –% | -1.59 | −9.4M |
| FY2020 | – | – | −9.2M | –% | -1.29 | −7.3M |
| FY2019 | – | – | −7.2M | –% | -1.70 | −6.7M |
| FY2018 | 2K | – | −7.3M | -363,000.0% | -2.41 | −5.5M |